Pacira Pharmaceuticals buy HC Wainwright
Start price
08.04.25
/
50%
€24.00
Target price
08.04.26
€59.31
Performance (%)
-22.50%
Price
18.07.25
€18.80
Summary
This prediction is currently active. The prediction for Pacira Pharmaceuticals disappoints with a performance of -22.50%. This prediction currently runs until 08.04.26. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Pacira Pharmaceuticals | -5.528% | -5.528% |
| iShares Core DAX® | -0.100% | 3.824% |
| iShares Nasdaq 100 | 1.827% | 4.852% |
| iShares Nikkei 225® | -0.370% | -1.695% |
| iShares S&P 500 | 1.185% | 4.017% |
Comments by HC_Wainwright for this prediction
In the thread Pacira Pharmaceuticals diskutieren
Pacira BioSciences, Inc. (NASDAQ: PCRX) had its price target raised by analysts at HC Wainwright from $48.00 to $65.00. They now have a "buy" rating on the stock.
Ratings data for PCRX provided by MarketBeat
Stopped prediction by HC_Wainwright for Pacira Pharmaceuticals
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€24.20
28.02.25
28.02.25
€67.25
28.02.26
28.02.26
-23.14%
18.07.25
18.07.25
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€16.20
04.12.24
04.12.24
€37.19
04.12.25
04.12.25
20.37%
18.07.25
18.07.25
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€21.20
02.07.24
02.07.24
€53.05
02.07.25
02.07.25
-8.96%
03.07.25
03.07.25
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€26.80
08.05.24
08.05.24
€53.04
08.05.25
08.05.25
-25.75%
09.05.25
09.05.25
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€26.20
04.03.24
04.03.24
€52.53
04.03.25
04.03.25
-15.27%
05.03.25
05.03.25
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€28.40
06.11.23
06.11.23
€53.07
06.11.24
06.11.24
-42.96%
07.11.24
07.11.24